These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37245837)

  • 1. "Shedding" low yield testing for telogen effluvium: A cross-sectional study of 16,381 laboratory results from newly diagnosed patients.
    Miller RC; Abedian S; Lipner SR
    J Am Acad Dermatol; 2023 Sep; 89(3):623-626. PubMed ID: 37245837
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
    Daunton A; Harries M; Sinclair R; Paus R; Tosti A; Messenger A
    Am J Clin Dermatol; 2023 Jul; 24(4):513-520. PubMed ID: 37052778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of zinc in chronic telogen effluvium in serum and hair of patients with alopecia.
    Zufishan S; Haque Z; Nazar S; Afaq E; Aamir E; Rafique S
    J Pak Med Assoc; 2024 Feb; 74(1 (Supple-2)):S47-S50. PubMed ID: 38385471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 infection is a major cause of acute telogen effluvium.
    Sharquie KE; Jabbar RI
    Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute telogen effluvium triad after resolution.
    Contin LA; Rocha VB
    An Bras Dermatol; 2021; 96(5):605-608. PubMed ID: 34272075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom?
    Öner Ü; Akdeniz N
    Turk J Med Sci; 2022 Feb; 52(1):188-194. PubMed ID: 34688244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of laboratory monitoring in newly diagnosed telogen effluvium patients.
    Miller RC; Curtis KL; Abedian S; Lipner SR
    Arch Dermatol Res; 2024 Jun; 316(7):388. PubMed ID: 38878196
    [No Abstract]   [Full Text] [Related]  

  • 9. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium.
    Yorulmaz A; Hayran Y; Ozdemir AK; Sen O; Genc I; Gur Aksoy G; Yalcin B
    J Cosmet Dermatol; 2022 Jun; 21(6):2610-2617. PubMed ID: 34449961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent modalities in treatment of telogen effluvium: Comparative study.
    Khattab FM; Rady A; Khashaba SA
    Dermatol Ther; 2022 Oct; 35(10):e15720. PubMed ID: 35851518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium.
    Savci U; Senel E; Oztekin A; Sungur M; Erel O; Neselioglu S
    An Bras Dermatol; 2020; 95(4):447-451. PubMed ID: 32482549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing and treating hair loss.
    Mounsey AL; Reed SW
    Am Fam Physician; 2009 Aug; 80(4):356-62. PubMed ID: 19678603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study.
    Bedair NI; Abdelaziz AS; Abdelrazik FS; El-Kassas M; AbouHadeed MH
    Arch Dermatol Res; 2024 Jun; 316(6):336. PubMed ID: 38844670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic telogen effluvium.
    Whiting DA
    Dermatol Clin; 1996 Oct; 14(4):723-31. PubMed ID: 9238330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata--part II.
    Werner B; Mulinari-Brenner F
    An Bras Dermatol; 2012; 87(6):884-90. PubMed ID: 23197208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of telogen effluvium in COVID-19 in western Iran (2020).
    Babaei K; Kavoussi H; Rezaei M; Kavoussi R
    An Bras Dermatol; 2021; 96(6):688-692. PubMed ID: 34593265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory Testing in Telogen Effluvium.
    Kakpovbia E; Ogbechie-Godec OA; Shapiro J; Lo Sicco KI
    J Drugs Dermatol; 2021 Jan; 20(1):110-111. PubMed ID: 33400415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
    El-Dawla RE; Abdelhaleem M; Abdelhamed A
    Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B; Onamusi T; Cooley JE; McMichael AJ
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin and Mineral Deficiencies in Patients With Telogen Effluvium: A Retrospective Cross-Sectional Study.
    Cheung EJ; Sink JR; English Iii JC
    J Drugs Dermatol; 2016 Oct; 15(10):1235-1237. PubMed ID: 27741341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.